phenylalanylarginine has been researched along with lorglumide in 1 studies
| Studies (phenylalanylarginine) | Trials (phenylalanylarginine) | Recent Studies (post-2010) (phenylalanylarginine) | Studies (lorglumide) | Trials (lorglumide) | Recent Studies (post-2010) (lorglumide) |
|---|---|---|---|---|---|
| 17 | 0 | 10 | 199 | 0 | 13 |
| Protein | Taxonomy | phenylalanylarginine (IC50) | lorglumide (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.034 | |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, T; Kagebayashi, T; Kino, K; Kontani, N; Mizushige, T; Ohinata, K; Yamada, Y | 1 |
1 other study(ies) available for phenylalanylarginine and lorglumide
| Article | Year |
|---|---|
Novel CCK-dependent vasorelaxing dipeptide, Arg-Phe, decreases blood pressure and food intake in rodents.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cholecystokinin; Dipeptides; Eating; Enteroendocrine Cells; Enzyme Inhibitors; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide; Proglumide; Prostaglandins; Rats; Rats, Inbred SHR; Receptors, Cholecystokinin; Vasodilator Agents | 2012 |